Charles M. Miller

Surgical Aspects of Deceased Donor Transplantation
20210 citationsauthor #4
Factors predicting futility of liver transplant in elderly recipients: A single-center experience
20215 citationsauthor #4
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial
20214 citationsauthor #13
Liver Transplantation in the United Arab Emirates From Deceased and Living Donors: Initial 2-Year Experience.
20214 citationsauthor #2
Conditional probability of graft survival in liver transplantation using donation after circulatory death grafts – a retrospective study
202118 citationsauthor #12
Neuroendocrine liver metastases: The role of liver transplantation.
202113 citationsauthor #10
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation.
202192 citationsauthor #42
The Concept of Functional Graft Size: an Eternal Theme of Maximizing Donor Safety and Recipient Survival in Living Donor Liver Transplantation.
202111 citationsauthor #2
Severe Outflow Obstruction After Liver Transplantation: Rescue Stapled Cavo‐Cavostomy via the Right Atrial Approach and Hypothermic Circulatory Arrest
20201 citationsauthor #10
Uterus Recovery from Deceased Donor: Simple Technique Securing Safety of Vital Organs and Uterus Graft.
202011 citationsauthor #8
Does Graft Hemodynamics Affect the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation?
20201 citationsauthor #10
Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus
202015 citationsauthor #8
Successful orthotopic liver transplantation in a patient with a positive SARS-CoV2 test and acute liver failure secondary to acetaminophen overdose
202040 citationsauthor #10
Establishment of Solid Organ Transplantation in the United Arab Emirates
202010 citationsauthor #3
Discovery and Validation of a Biomarker Model (PRESERVE) Predictive of Renal Outcomes After Liver Transplantation
202017 citationsauthor #7
Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis.
202016 citationsauthor #10
Three-dimensional (3D) printing and liver transplantation
20203 citationsauthor #4
Discovery and validation of a novel blood‐based molecular biomarker of rejection following liver transplantation
202038 citationsauthor #6
Should We Be Utilizing More Liver Grafts From Pediatric Donation After Circulatory Death Donors? A National Analysis of the SRTR from 2002 to 2017
20204 citationsauthor #12
LIVER TRANSPLANTATION IN THE UNITED ARAB EMIRATES: INITIAL TWO-YEAR EXPERIENCE
20201 citationsauthor #2
Sufficient hepatic artery flow compensates for poor portal vein flow after liver transplantation in patients with portal vein thrombosis
20195 citationsauthor #14
Predictive Value of Hepatic Venous Pressure Gradient for Graft Hemodynamics in Living Donor Liver Transplantation
201915 citationsauthor #10
A new technique for hepatic parenchymal transection using an articulating bipolar 5 cm radiofrequency device: results from the first 100 procedures.
20184 citationsauthor #6
Outcomes following Stereotactic Body Radiation Therapy for Patients with Child-Pugh B or C Hepatocellular Carcinoma
20181 citationsauthor #8
HALTHCC as a novel tumor response metric in patients with hepatocellular carcinoma undergoing locoregional therapy while awaiting liver transplantation
20180 citationsauthor #8
American Society for Reproductive Medicine position statement on uterus transplantation: a committee opinion.
201859 citationsauthor #15
Renoportal anastomosis in liver transplantation and its impact on patient outcomes: a systematic literature review
201826 citationsauthor #10
Evaluation of Flagging Criteria of United States Kidney Transplant Center Performance: How to Best Define Outliers?
201723 citationsauthor #2
Laparoscopic versus open 1-stage resection of synchronous liver metastases and primary colorectal cancer.
201716 citationsauthor #11
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
201784 citationsauthor #10
Probability, management, and long‐term outcomes of biliary complications after hepatic artery thrombosis in liver transplant recipients
201736 citationsauthor #8
The Cleveland clinic score for liver transplantation for hepatocellular carcinoma: continuous prognostic score using tumor morphology and biology
20170 citationsauthor #10
A matched comparison of liver resection and laparoscopic radiofrequency ablation for colorectal liver metastases based on tumor burden and ASA status
20170 citationsauthor #6
Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria
201615 citationsauthor #3
The International Liver Transplant Society Guideline on Living Liver Donation.
201677 citationsauthor #1
Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastases.
20169 citationsauthor #4
The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline
2016106 citationsauthor #1
Safety and Efficacy of a New Bipolar Energy Device for Parenchymal Dissection in Laparoscopic Liver Resection
201613 citationsauthor #7
Recurrence of Metabolic Disorders After Liver Transplantation
20160 citationsauthor #2
Split liver transplantation in adults
201633 citationsauthor #9
Clinical outcomes of resected biliary tract cancer: A cohort study.
20160 citationsauthor #5
Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients.
201614 citationsauthor #7
Rejection triggers liver transplant tolerance: Involvement of mesenchyme‐mediated immune control mechanisms in mice
201536 citationsauthor #3
880 Concomitant Surgical Management of Synchronous Colorectal Cancer and Liver Metastases: A Comparison of Open and Laparoscopic Approaches
20150 citationsauthor #10
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5‐year experience
201543 citationsauthor #13
Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic
201538 citationsauthor #9
Metzenbaum-Assisted Liver Resection: A Safe and Effective Liver Resection Technique
20143 citationsauthor #2
Elimination of Activated T Cells Is Pre-Condition for Immune Suppressor Cells to Induce Transplant Tolerance.: Abstract# 2142
20140 citationsauthor #2
Techniques for Living Donor Liver Procurement
20141 citationsauthor #3
State of the Art and Future Developments for Surgical Planning in LDLT
201411 citationsauthor #5
Role of Vasodilation during Normothermic Machine Perfusion of DCD Porcine Livers
201442 citationsauthor #11
Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies.
201326 citationsauthor #9
49-P : MULTI-SUBSET DONOR LYMPHOID CHIMERISM PATTERNS DURING ACUTE GRAFT VERSUS HOST DISEASE AFTER LIVER TRANSPLANT
20130 citationsauthor #3
Laparoscopic versus open resection of colorectal liver metastasis
201369 citationsauthor #7
Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications.
201325 citationsauthor #12
Comparable graft and patient survival in lean and obese liver transplant recipients
201371 citationsauthor #7
SY-14-KL Preparing for the inevitable death of a living donor improves LDLT programmatic safety
20130 citationsauthor #1
Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
201312 citationsauthor #3
Multicentre results of stereotactic body radiotherapy for secondary liver tumours.
201336 citationsauthor #12
Is there an advantage of living over deceased donation in liver transplantation?
201334 citationsauthor #4
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors
2012123 citationsauthor #12
Use of 3-dimensional imaging reconstruction in the treatment of advanced intra-abdominal desmoid tumors.
20121 citationsauthor #5
Incentives for Organ Donation: Proposed Standards for an Internationally Acceptable System
201294 citationsauthor #35
Living donor liver transplantation: ethical considerations.
201213 citationsauthor #1
Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis.
201222 citationsauthor #9
Stereotactic Radiation (SBRT) for Primary Liver Malignancies
20121 citationsauthor #7
461 Outcome of Patients With Hepatocellular Carcinoma Beyond Milan Criteria
20120 citationsauthor #3
Organ Transplantation: Living donor liver transplantation
20111 citationsauthor #3
Hepatic blood flow plays an important role in ischemia‐reperfusion injury
201147 citationsauthor #10
Future prospects in immunosuppression for liver transplantation
20116 citationsauthor #3
Short segment aortic endarterectomy – a technique to aid cannulation in donors with severe aorto‐iliac disease
20110 citationsauthor #5
Multicenter Results of Stereotactic Body Radiotherapy (SBRT) for Secondary Tumors of the Liver
20110 citationsauthor #14
Splenic artery embolization for the treatment of refractory ascites after liver transplantation
201139 citationsauthor #10
Insulin-like growth factor I receptor β expression in hepatocellular carcinoma.
20119 citationsauthor #5
Outcome of Locoregional Therapy for Hepatocellular Carcinoma (HCC) Before Liver Transplantation
20110 citationsauthor #5
Outcomes of simultaneous liver transplantation and elective cardiac surgical procedures.
201138 citationsauthor #3
,-1 ORGAN PROCUREMENT Approach to the Potential Organ Donor Preliminary Steps
20100 citationsauthor #2
Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients?
201041 citationsauthor #2
Post–Liver Transplantation Management
20104 citationsauthor #2
Deep hypothermia with circulatory arrest to aid in the management of suprahepatic vena cava stenosis after liver transplantation
20102 citationsauthor #6
Surgical resection for advanced gallbladder carcinoma. The Mount Sinai experience.
20104 citationsauthor #6
Multifocal cholangiocarcinoma in an explanted liver allograft following retransplant for recurrent primary sclerosing cholangitis.
20102 citationsauthor #3
Univariate and Multivariate Analysis of Prognostic Factors in the Surgical Treatment of Hilar Cholangiocarcinoma
201036 citationsauthor #14
An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation.
201061 citationsauthor #6
Vascular endothelial growth factor receptor 2 expression in non‐tumorous cirrhotic liver is higher when hepatoma is beyond milan criteria
200923 citationsauthor #9
Transplant Tourism and Unregulated Black‐Market Trafficking of Organs
200914 citationsauthor #6
Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small‐for‐size syndrome
200965 citationsauthor #13
Side‐to‐side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique
200926 citationsauthor #2
Lack of killer immunoglobulin‐like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients
200924 citationsauthor #8
Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
200881 citationsauthor #6
The use of marginal grafts in liver transplantation.
200853 citationsauthor #2
46-W: Donor lymphoid chimerism kinetics in a successfully treated case of acute graft versus host disease after orthotopic liver transplantation
20080 citationsauthor #6
Hepatic artery (HA) vasospasm in the small-for-size liver graft syndrome (SFSS) is independent of norepinephrine (NE)
20080 citationsauthor #7
Ethical dimensions of living donation: experience with living liver donation.
200853 citationsauthor #1
Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome.
2008120 citationsauthor #6
KIDNEY TRANSPLANT LISTING FOLLOWING, LIVER, HEART AND LUNG TRANSPLANTATION: 416
20080 citationsauthor #5
Triple‐phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation
200839 citationsauthor #10
Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
200865 citationsauthor #2
Recurrent hepatitis C after liver transplantation: On‐treatment prediction of response to peginterferon/ribavirin therapy
200875 citationsauthor #2
Vascular endothelial growth factor receptor 2 (VEGFr2) expression and recurrence of hepatocellular carcinoma following liver transplantation: The Cleveland Clinic experience
20087 citationsauthor #7

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT